Human infection with highly pathogenic avian influenza a(H7N9) virus, China

Emerging Infectious Diseases

Volumn 23, Issue 8, 2017, Pages 1332-1340

  Ke, Changwen ^a   Mok, Chris Ka Pun ^b   Zhu, Wenfei ^d   Zhou, Haibo ^b   He, Jianfeng ^a   Guan, Wenda ^b,c   Wu, Jie ^a   Song, Wenjun ^e   Wang, Dayan ^d   Liu, Jiexiong ^b   Lin, Qinhan ^b   Chu, Daniel Ka Wing ^c   Yang, Lei ^d   Zhong, Nanshan ^b,f   Yang, Zifeng ^b,f   Shu, Yuelong ^d   Peiris, Joseph Sriyal Malik ^b,c  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d National Institute for Viral Disease Control and Prevention   (China)

^e JINAN UNIVERSITY   (China)

^f MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CEFOPERAZONE PLUS SULBACTAM; CREATININE; D DIMER; GANCICLOVIR; HEMOGLOBIN; LACTATE DEHYDROGENASE; NORADRENALIN; OSELTAMIVIR; PERAMIVIR; PROCALCITONIN; VIRUS RNA; INFLUENZA VIRUS HEMAGGLUTININ;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY TITER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; HEMAGGLUTINATION INHIBITION TEST; HIGHLY PATHOGENIC AVIAN INFLUENZA; HUMAN; HUMAN TISSUE; INFLUENZA A VIRUS (H7N9); LUNG INFILTRATE; MALE; MIDDLE AGED; PHYLOGENY; PNEUMONIA; REAL TIME POLYMERASE CHAIN REACTION; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; UREA NITROGEN BLOOD LEVEL; VIRUS LOAD; ANIMAL; AVIAN INFLUENZA; BIRD DISEASE; CHEMISTRY; CHICKEN; CHINA; CLASSIFICATION; COMPLICATION; CYTOMEGALOVIRUS INFECTION; FATALITY; INFLUENZA; MEAT; TRANSMISSION; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; CHICKENS; CHINA; CYTOMEGALOVIRUS INFECTIONS; FATAL OUTCOME; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MALE; MEAT; MIDDLE AGED; POULTRY DISEASES;

EID: 85025107232     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2308.170600     Document Type: Article

References (23)

1. World Heath Organization. Human infection with avian influenza A(H7N9) virus—China. Disease outbreak news 2017 Feb 20 [cited 2017 May 1]. http://www.who.int/csr/don/20-february-2017-ah7n9-china/en/
2. World Heath Organization. Human infection with avian influenza A(H7N9) virus—China. Disease outbreak news 2017 Feb 22 [cited 2017 May 1]. http://www.who.int/csr/don/22-february-2017-ah7n9-china/en/
3. Qin Y, Horby PW, Tsang TK, Chen E, Gao L, Ou J, et al. Differences in the epidemiology of human cases of avian influenza A(H7N9) and A(H5N1) viruses infection. Clin Infect Dis. 2015;61:563–71. http://dx.doi.org/10.1093/cid/civ345
4. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, Tsang TK, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013;382:138–45. http://dx.doi.org/10.1016/S0140-6736(13)61207-6
5. Chen Z, Liu H, Lu J, Luo L, Li K, Liu Y, et al. Asymptomatic, mild, and severe influenza A(H7N9) virus infection in humans, Guangzhou, China. Emerg Infect Dis. 2014;20:1535–40. http://dx.doi.org/10.3201/eid2009.140424
6. Lin YP, Yang ZF, Liang Y, Li ZT, Bond HS, Chua H, et al. Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China. BMC Infect Dis. 2016;16:632. http://dx.doi.org/10.1186/s12879-016-1983-3
7. Lam TT, Zhou B, Wang J, Chai Y, Shen Y, Chen X, et al. Dissemination, divergence and establishment of H7N9 influenza viruses in China. Nature. 2015;522:102–5. http://dx.doi.org/10.1038/nature14348
8. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–97. http://dx.doi.org/10.1056/NEJMoa1304459
9. Chan MC, Chan RW, Chan LL, Mok CK, Hui KP, Fong JH, et al. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med. 2013;1:534–42. http://dx.doi.org/10.1016/S2213-2600(13)70138-3
10. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013;341:183–6. http://dx.doi.org/10.1126/science.1239844
11. Luczo JM, Stambas J, Durr PA, Michalski WP, Bingham J. Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif. Rev Med Virol. 2015;25:406–30. http://dx.doi.org/10.1002/rmv.1846
12. Schrauwen EJ, Herfst S, Leijten LM, van Run P, Bestebroer TM, Linster M, et al. The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol. 2012;86:3975–84. http://dx.doi.org/10.1128/JVI.06828-11
13. World Organisation for Animal Health and Food and Agriculture Organization Influenza. Influenza A cleavage sites [cited 2017 Feb 24]. http://www.offlu.net/fileadmin/home/en/resource-centre/pdf/Influenza_A_Cleavage_Sites.pdf
14. Yang JR, Liu MT. Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J Formos Med Assoc. 2017;116:210–2. http://dx.doi.org/10.1016/j.jfma.2017.02.011
15. Zhang F, Bi Y, Wang J, Wong G, Shi W, Hu F, et al. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J Infect. 2017;S0163-4453(17)30108-1.
16. Suguitan AL Jr, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, et al. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals. J Virol. 2012;86:2706–14. http://dx.doi.org/10.1128/JVI.05546-11
17. Zeng H, Pappas C, Belser JA, Houser KV, Zhong W, Wadford DA, et al. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J Virol. 2012;86:667–78. http://dx.doi.org/10.1128/JVI.06348-11
18. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85. http://dx.doi.org/10.1056/zNEJMoa1305584
19. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet. 2013;381:2273–9. http://dx.doi.org/10.1016/S0140-6736(13)61125-3
20. Yen HL, McKimm-Breschkin JL, Choy KT, Wong DD, Cheung PP, Zhou J, et al. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population. MBio. 2013;4: e00396-13. http://dx.doi.org/10.1128/mBio.00396-13
21. Mok CK, Lee HH, Lestra M, Nicholls JM, Chan MC, Sia SF, et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol. 2014;88:3568–76. http://dx.doi.org/10.1128/JVI.02740-13
22. Neumann G, Kawaoka Y. Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis. 2006; 12:881–6. http://dx.doi.org/10.3201/eid1206.051336
23. Yamayoshi S, Fukuyama S, Yamada S, Zhao D, Murakami S, Uraki R, et al. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts. Sci Rep. 2015;5:8039. http://dx.doi.org/10.1038/srep08039